These results, together with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 guidance the strategy of focusing on ACKR3 as a unique strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Conditions. January 3, 2024 Donating https://reidpafgi.targetblogs.com/27215264/5-easy-facts-about-conolidine-described